Liqing Kang
Overview
Explore the profile of Liqing Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo X, Cao N, Deng X, Wang N, Li R, Ren S, et al.
Sci Rep
. 2025 Mar;
15(1):8172.
PMID: 40059242
This study aimed to determine whether intermuscular adipose tissue (IMAT) or intramuscular adipose tissue content (IMAC) has a greater effect on skeletal muscle density (SMD) and to explore the underlying...
2.
Chu Y, Zhou B, Gao R, Miao M, Qiu H, Tang X, et al.
Blood Cancer J
. 2025 Feb;
15(1):11.
PMID: 39910042
No abstract available.
3.
Yan Y, Tu Y, Cheng Q, Zhang J, Wang E, Deng Z, et al.
J Transl Med
. 2024 Nov;
22(1):1087.
PMID: 39614361
Background: B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR T-cell) therapy has exhibited remarkable efficacy in refractory or relapsed multiple myeloma (R/R MM), but recurrence and rapid progression of...
4.
Sun M, Kang L, Cui Y, Li G
Exp Ther Med
. 2024 Sep;
28(6):431.
PMID: 39347496
[This retracts the article DOI: 10.3892/etm.2018.6349.].
5.
Xu X, Liu F, Zhao X, Wang C, Li D, Kang L, et al.
Front Oncol
. 2024 Sep;
14:1417933.
PMID: 39323994
Purpose: To investigate the value of multiparameter MRI of early cervical cancer (ECC) combined with pre-treatment serum squamous cell carcinoma antigen (SCC-Ag) in predicting its pelvic lymph node metastasis (PLNM)....
6.
Li T, Cui Q, Liu S, Li Z, Cui W, Li M, et al.
Leuk Res
. 2024 Aug;
145:107569.
PMID: 39208598
Objective: We aimed to evaluate the efficacy of decitabine consolidation after treatment with CD19/CD22 chimeric antigen receptor T-cell (CAR-T) for patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL). Methods:...
7.
Liu J, Xu M, Zhang X, Zhang Z, Zhong T, Yu H, et al.
Heliyon
. 2024 Jul;
10(13):e33937.
PMID: 39055833
Chimeric antigen receptor (CAR)-T cell therapy has been confirmed improving remission rates in refractory patients or relapsed B-cell acute lymphoblastic leukemia (R/R B-ALL). However, the added benefits of undergoing allogeneic...
8.
Niu X, Dun Y, Li G, Zhang H, Zhang B, Pan Z, et al.
BMC Med Imaging
. 2024 Jun;
24(1):131.
PMID: 38840059
Purpose: To evaluate the intracavity left ventricular (LV) blood flow kinetic energy (KE) parameters using four-dimensional (4D) flow cardiovascular magnetic resonance (CMR) in patients with acute myocardial infarction (AMI). Methods:...
9.
Wang X, Sun M, Kang L
BJR Case Rep
. 2024 May;
10(3):uaae011.
PMID: 38699520
We describe a case of gallbladder extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-ML). MALT-ML is rare, and its clinical manifestations are lack of specificity. A few cases...
10.
Li Y, Cui Q, Liu S, Liu L, Li M, Gao J, et al.
Cell Oncol (Dordr)
. 2024 Apr;
47(5):1649-1661.
PMID: 38662336
Purpose: Despite chimeric antigen receptor (CAR) T-cell therapy has achieved great advances in recent year, approximately 50% of relapsed/refractory B cell acute lymphoblastic leukemia (r/r B-ALL) patients treated with CAR-T...